Latest Expert Opinions

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
February 11, 2019
(A Top Pick Mar 20/18, Down 1%) He still thinks it is amazing. There is still massive growth in front of them.
Show full opinionHide full opinion
Facebook (FB-Q)
February 11, 2019
(A Top Pick Mar 20/18, Down 1%) He still thinks it is amazing. There is still massive growth in front of them.
PAST TOP PICK
PAST TOP PICK
February 11, 2019
(A Top Pick Mar 20/18, Down 0.2%) It was one of his hopes in the medical area for great growth. They are being acquired. He is going to keep holding it.
Show full opinionHide full opinion
Celgene Corp (CELG-Q)
February 11, 2019
(A Top Pick Mar 20/18, Down 0.2%) It was one of his hopes in the medical area for great growth. They are being acquired. He is going to keep holding it.
PAST TOP PICK
PAST TOP PICK
February 11, 2019
(A Top Pick Mar 20/18, Down 33%) He has owned it since it went public. It has had a lot of ups and downs but is an incredibly well managed company. They have lift access as well as farm machinery businesses in addition to auto parts. He would not hesitate to buy it.
Show full opinionHide full opinion
Linamar Corp (LNR-T)
February 11, 2019
(A Top Pick Mar 20/18, Down 33%) He has owned it since it went public. It has had a lot of ups and downs but is an incredibly well managed company. They have lift access as well as farm machinery businesses in addition to auto parts. He would not hesitate to buy it.
HOLD
HOLD
February 11, 2019
It is well managed. They made a plethora of acquisitions. They are making tiny ones with a model that works. Don’t sell a company doing this well, although he prefers OTEX-T, which is a more sure bet. (Analysts’ price target is $11.32)
Show full opinionHide full opinion
It is well managed. They made a plethora of acquisitions. They are making tiny ones with a model that works. Don’t sell a company doing this well, although he prefers OTEX-T, which is a more sure bet. (Analysts’ price target is $11.32)
BUY
BUY
February 11, 2019
They are a core holding in the medical area. They have done well recently. They will not make a home run because they make commodities. They are big and they dominate the business. As hospital spending picks up they will get their share. You will get more upside from other companies if their drugs come through. He would not hesitate to own ABT-N. It is slow and steady.
Show full opinionHide full opinion
Abbott Labs (ABT-N)
February 11, 2019
They are a core holding in the medical area. They have done well recently. They will not make a home run because they make commodities. They are big and they dominate the business. As hospital spending picks up they will get their share. You will get more upside from other companies if their drugs come through. He would not hesitate to own ABT-N. It is slow and steady.
HOLD
HOLD
February 11, 2019
They suffered badly. It is going to disappear as they are being acquired. You could hold it from here.
Show full opinionHide full opinion
Goldcorp Inc (G-T)
February 11, 2019
They suffered badly. It is going to disappear as they are being acquired. You could hold it from here.
DON'T BUY
DON'T BUY
February 11, 2019
They have hope for a bunch of new products. There is heavy competition with slow growth. He prefers OTEX-T, FB-Q, or GOOGL-Q.
Show full opinionHide full opinion
BlackBerry (BB-T)
February 11, 2019
They have hope for a bunch of new products. There is heavy competition with slow growth. He prefers OTEX-T, FB-Q, or GOOGL-Q.